- Filed
- May 16, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · May 12, 2022 | 138.1M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2022 | 137.85M sh |
| Shares Diluted | Q1 2022 · Mar 31, 2021 | 108.66M sh |
| Capex | Q1 2022 · Mar 31, 2022 | $501K |
| Capex | Q1 2022 · Mar 31, 2021 | $789K |
| Operating Cash Flow | Q1 2022 · Mar 31, 2022 | −$36.71M |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | −$20.96M |
| Long Term Debt | Q1 2022 · Mar 31, 2022 | $0 |
| Short Term Debt | Q1 2022 · Mar 31, 2022 | $27.17M |
| Short Term Debt | Q1 2022 · Dec 31, 2021 | $26.99M |
| Short Term Investments | Q1 2022 · Mar 31, 2022 | $47.97M |
| Short Term Investments | Q1 2022 · Dec 31, 2021 | $5M |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $89.43M |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $169.57M |
| Stockholders Equity | Q1 2022 · Mar 31, 2022 | $69.51M |
| Stockholders Equity | Q1 2022 · Dec 31, 2021 | $90.43M |
| Stockholders Equity restated | Q1 2022 · Mar 31, 2021 | $85.56M |
| Stockholders Equity restated | Q1 2022 · Dec 31, 2020 | $87.12M |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $46.38M |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $47.17M |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $102.58M |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $106.73M |
| Current Assets | Q1 2022 · Mar 31, 2022 | $150.05M |
| Current Assets | Q1 2022 · Dec 31, 2021 | $185.24M |
| Total Assets | Q1 2022 · Mar 31, 2022 | $172.09M |
| Total Assets | Q1 2022 · Dec 31, 2021 | $197.16M |
| Eps Diluted | Q1 2022 · Mar 31, 2022 | −$0.17 |
| Eps Diluted | Q1 2022 · Mar 31, 2021 | −$0.22 |
| Eps Basic | Q1 2022 · Mar 31, 2022 | −$0.17 |
| Eps Basic | Q1 2022 · Mar 31, 2021 | −$0.22 |
| Sga Expense | Q1 2022 · Mar 31, 2022 | $22.75M |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $13.3M |
| Rd Expense | Q1 2022 · Mar 31, 2022 | $13.26M |
| Rd Expense | Q1 2022 · Mar 31, 2021 | $7.49M |
| Net Income | Q1 2022 · Mar 31, 2022 | −$23.86M |
| Net Income restated | Q1 2022 · Mar 31, 2021 | −$24.39M |
| Operating Income | Q1 2022 · Mar 31, 2022 | −$34.74M |
| Operating Income restated | Q1 2022 · Mar 31, 2021 | −$21.15M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2022 | $1.48M |
| Cost Of Revenue | Q1 2022 · Mar 31, 2021 | $738K |
| Revenue | Q1 2022 · Mar 31, 2022 | $2.75M |
| Revenue | Q1 2022 · Mar 31, 2021 | $376K |